{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UA-BP-SC-00342",
      "entity_text" : "ADR",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ05378",
      "entity_text" : "apatinib",
      "entity_type" : "protein"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "The ADR rates for nausea, vomiting, hemoglobin decrease, proteinuria, and hypertension were significantly higher in the combined group than those in the control group (P < 0.05), suggesting that the combined use of tegafur and apatinib might enhance the ADR rate during treatment.",
  "reading_complete" : "2020-08-08T13:24:58Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T13:22:44Z",
  "trigger" : "enhance",
  "evidence" : [ "apatinib might enhance the ADR" ],
  "pmc_id" : "7165347",
  "score" : 0
}